Purchase Order HHSN268201700373A
Award Date 9/26/17
Potential Completion Date 10/26/17
Potential Value $96K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed-price delivery order awarded by the National Heart Lung and Blood Institute (NHLBI), part of the National Institutes of Health (NIH), to Illumina, Inc., a biotechnology company specializing in genetic sequencing and genomic analysis technologies. The $48,994.05 contract is for the procurement of an Illumina MiSeq I100 sequencing system and associated reagents and services, to support high-quality DNA sequencing and genomic research at NHLBI. The contract has an ultimate...
- This is a firm fixed price purchase order awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Illumina, Inc. for the acquisition of an Illumina MiSeq System. The contract has a ceiling value of $95,931.00 and a completion date of August 31, 2019. Illumina is a manufacturer of genetic sequencing and analysis instruments and reagents, and has received past prime contract awards from various federal agencies to support their...
- This $95,931.00 firm fixed price purchase order was awarded by the National Institute of Environmental Health Sciences (NIEHS), a civilian federal agency, to Illumina, Inc., a for-profit manufacturer of genomic sequencing instruments and related products. The contract is for the provision of a MiSeq System, a genetic analysis platform used in life science research, applied markets, and molecular diagnostics. Illumina has a history of providing sequencing systems and consumables to support...
- This is a $15,849.80 firm fixed price purchase order awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Illumina, Inc. The contract is for the maintenance of a MiSeq M06580 DNA sequencing instrument and associated services. The contract has a period of performance through September 11, 2026. Illumina, a manufacturer of genomic sequencing technologies, has been awarded multiple federal contracts and grants by the NIH, Centers...
- This is a $89,238.80 firm fixed-price purchase order awarded by the National Institute of Environmental Health Sciences (NIEHS), a component of the National Institutes of Health (NIH), to Illumina, Inc. The contract is for the provision of an ILLUMINA MISEQ I100 PLUS SEQUENCER to replace an existing system in the NIEHS Epigenomics Core Laboratory. The contract has an ultimate completion date of September 9, 2026. Illumina, Inc. is a for-profit biotechnology company that specializes in genetic...
- This is a firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Illumina, Inc. for the purchase of a MiSeq System sequencing platform. The contract has a ceiling value of $95,931.00 and a completion date of August 21, 2014. Illumina is a manufacturer of sequencing and genomic analysis instruments and reagents that has previously provided such products and services to various federal...
- This is a firm fixed price purchase order contract awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Illumina, Inc. The contract has a ceiling value of $646,396.36 and no set-aside designation. Illumina, a manufacturer of sequencing and array-based genomic analysis solutions, will provide a range of sequencing systems, reagents, and services to support NHLBI's research and diagnostics needs. Illumina has a history of...
- This is a firm fixed price purchase order contract awarded by the Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute to Illumina, Inc., a for-profit manufacturer of genomic sequencing systems and related products. The contract is for the provision of a NEXTSEQ 1000 SEQUENCING SYSTEM, with a potential value of $142,100.00. The contract does not have a set-aside designation and is expected to be completed by April 14, 2025. Illumina has...
- This is a firm fixed price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Illumina, Inc. for the provision of a MiSeq benchtop DNA sequencer system. The total ceiling value of the contract is $119,937.50, with a performance period ending on December 2, 2013. The contract does not have any set-aside designation. Illumina, a manufacturer and provider of sequencing and array-based solutions,...
- This is a firm fixed price purchase order contract awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Heart Lung and Blood Institute to Illumina, Inc., a for-profit manufacturer of genomic sequencing and analysis instruments and reagents. The $190,561.89 contract is for Illumina's sequencing services and is not set-aside. Illumina has provided similar sequencing goods and services to support research and diagnostics for various federal...